Back
ESC Premium Access

Newer P2Y12 inhibitors in a real-world setting: long-term outcomes from contemporary PCI with newer versus traditional dual antiplatelet regimes.

Session: Antiplatelet therapy in PCI
Topic: Antiplatelet Drugs
Speaker: Doctor M. Mohamed (London, GB)
Event: ESC Congress 2018

Congress Presentation

0

About the speaker

Doctor Mohamed Mohamed

University College London, London (United Kingdom of Great Britain & Northern Ireland)
0 follower

4 more presentations in this session

Antiplatelet therapy - State of the art

Speaker: Associate Professor B. Rocca (Rome, IT)

Access
Slides
Video
0
Thumbnail

Association of plasma concentration of trimethylamine N-oxide and ADP-induced platelet reactivity after a loading dose of clopidogrel 600 mg in patients undergoing elective PCI

Speaker: Professor D. Trenk (Bad Krozingen, DE)

Access
Abstract
0
Thumbnail

Meta-analysis of use of proton pump inhibitors with dual antiplatelet therapy after acute coronary syndrome

Speaker: Doctor E. Kaluski (Sayre, US)

Access
Abstract
Slides
Video
0
Thumbnail

The future of DAPT

Speaker: Professor R. Storey (Sheffield, GB)

Access
Slides
Video
0
Thumbnail

Access the full session

Antiplatelet therapy in PCI

Speakers: Doctor M. Mohamed, Associate Professor B. Rocca, Professor D. Trenk, Doctor E. Kaluski, Professor R. Storey
Access
0
Thumbnail

About the event

Image

ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk